Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation

August 14, 2019 updated by: Duangjun Phantayuth, Mahidol University
COPD patients will be recruited and assigned into one of each group: 1) Control group or 2) Yoga group. In Yoga groups, subjected will be asked to participate in Modified Dantien Yoga training for 12 weeks (3 times/week, 60 min/time). The subjects will be evaluated their pulmonary function, functional fitness performance, dyspnea score, and quality of life at baseline and after 12 wk training.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bangkok
      • Bangkoknoi, Bangkok, Thailand, 10700
        • Recruiting
        • Faculty of Medicine, Siriraj Hospital
        • Contact:
          • Arth Nana, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Stable COPD patients > or equal 6 weeks.
  2. Age > or equal 50-80 years.
  3. FEV1 > or equal 30% predicted after take bronchodilators drug.
  4. Resting SpO2 > or equal 90% room air.
  5. Did not pulmonary rehabilitation program before start the yoga

Exclusion Criteria:

  1. Subjects with musculoskeletal disorders, mental and neurological disorders, and acute coronary heart disease.
  2. Blood Pressure (systolic) > 180 mmHg.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Control group will be asked to continue their normal daily life without Yoga training
Experimental: Yoga group
Yoga group will be exposed to Modified Dantien Salee Yoga Training Program for 12 weeks
The intervention aims to improve pulmonary function and functional fitness.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline FVC (Forced Vital Capacity) (L) at 12 weeks
Time Frame: 12 weeks
Change of FVC (Forced Vital Capacity) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline FEV1 (Forced Expiratory Volume in 1 minute)(L) at 12 weeks
Time Frame: 12 weeks
Change of Forced Expiratory Volume in 1 second will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline TLC (Total Lung Capacity) (L) at 12 weeks
Time Frame: 12 weeks
Change of TLC (Total Lung Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline FRC (Functional Residual Capacity) (L) at 12 weeks
Time Frame: 12 weeks
Change of FRC (Functional Residual Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline IC (Inspiratoy Capacity) (L) at 12 weeks
Time Frame: 12 weeks
Change of IC (Inspiratoy Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline RV (Residual Volume) (L) at 12 weeks
Time Frame: 12 weeks
Change of RV (Residual Volume) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline MVV (Maximum Voluntary Ventilation) (L/min) at 12 weeks
Time Frame: 12 weeks
Change of MVV (Maximum Voluntary Ventilation) (L/min) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline PEFR (Peak Expiratory Flow Rate) (L/sec) at 12 weeks
Time Frame: 12 weeks
Change of MVV (Maximum Voluntary Ventilation) (L/sec) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline DLCO (Diffusion capacity to carbon monoxide) (ml/mmHg/min) at 12 weeks
Time Frame: 12 weeks
Change of DLCO (Diffusion capacity to carbon monoxide) (ml/mmHg/min) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline PI max (Maximal Inspiratoy Pressure) (cm H2O) at 12 weeks
Time Frame: 12 weeks
Change of PI max (Maximal Inspiratoy Pressure) (cm H2O) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline PE max (Maximal Expiratoy Pressure) (cm H2O) at 12 weeks
Time Frame: 12 weeks
Change of PE max (Maximal Expiratoy Pressure) (cm H2O) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline FEV1/FVC % predicted at 12 weeks
Time Frame: 12 weeks
Change of FEV1/FVC % Predicted (Percent Predicted of ratio of FEV1 and FVC) (% predicted) will be measured on a computerized Spirometer at the baseline and 12 weeks.
12 weeks
Change from baseline lower body strength assessed with Chair Standing test at 12 weeks
Time Frame: 12 weeks
Change from baseline lower body strength assessed with Chair standing test. ( time/30 sec)
12 weeks
Change from baseline upper body strength assessed with Arm curl test at 12 weeks
Time Frame: 12 weeks
Change from baseline upper body strength assessed with Arm curl test (time/30 sec)
12 weeks
Change from baseline lower body flexibility assessed with Chair Sit and Reach test at 12 weeks
Time Frame: 12 weeks
Change from baseline lower body flexibility assessed with Chair Sit and Reach test (cm)
12 weeks
Change from baseline upper body flexibility assessed with Back Scratch test at 12 weeks
Time Frame: 12 weeks.
Change from baseline upper body flexibility assessed with Back Scratch test (cm)
12 weeks.
Change from baseline agility/dynamic balance assessed with 8-foot Up and Go test at 12 weeks
Time Frame: 12 weeks
Change from baseline agility/dynamic balance assessed with 8-foot Up and Go test (sec)
12 weeks
Change from baseline Exercise Capacity assessed with 6-minute walk test at 12 weeks
Time Frame: 12 weeks
Change from baseline Exercise Capacity assessed with 6-minute walk test (meter)
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Dyspnea score assessed with visual analog scale at 12 weeks
Time Frame: 12 weeks
Dyspnea or shortness of breath will be measured by visual analog scale (VAS) 1-10 point scale at the baseline and 12 weeks.
12 weeks
Change from baseline Quality of life score assessed with St. George's respiratory Questionnaires (SGRQ) at 12 weeks.
Time Frame: 12 weeks
Change from baseline Quality of Life score assessed with St. George's respiratory Questionnaires (SGRQ) in Thai version at 12 weeks.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Amornpan Ajjimaporn, Ph.D, Mahidol

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2016

Primary Completion (Anticipated)

October 30, 2019

Study Completion (Anticipated)

October 30, 2019

Study Registration Dates

First Submitted

April 20, 2016

First Submitted That Met QC Criteria

May 10, 2016

First Posted (Estimate)

May 12, 2016

Study Record Updates

Last Update Posted (Actual)

August 16, 2019

Last Update Submitted That Met QC Criteria

August 14, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • MU-CIRB 2015/133.2808

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease, Chronic Obstructive

Clinical Trials on Modified Dantien Salee Yoga Training Program

Subscribe